CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance & Accounting sold 5,000 shares at an average $17.22 ($86,102)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 1,785,714 shares (conversion)
- 4 Open-market buy 10% owner bought 93,750 shares at $16.00 ($1,500,000)
- 4 Open-market buy 10% owner bought 81,250 shares at $16.00 ($1,300,000)
- 4 Open-market buy 10% owner bought 81,250 shares at $16.00 ($1,300,000)
- 4 Open-market buy 10% owner bought 118,750 shares at $16.00 ($1,900,000)
- 4 Open-market buy 10% owner bought 140,000 shares at an average $15.84 ($2,217,495)
- 4 Open-market buy Director bought 81,250 shares at $16.00 ($1,300,000)
- 4 Conversion 10% owner acquired 464,285 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 12 · 221 filings